Caffeine prophylaxis to improve intermittent hypoxaemia in infants born late preterm: a randomised controlled dosage trial (Latte Dosage Trial)

INTRODUCTION: Infants born late preterm (34+0 to 36+6 weeks’ gestational age) have frequent episodes of intermittent hypoxaemia compared with term infants. Caffeine citrate reduces apnoea and intermittent hypoxaemia and improves long-term neurodevelopmental outcomes in infants born very preterm and...

Descripción completa

Detalles Bibliográficos
Autores principales: Oliphant, Elizabeth Anne, McKinlay, Christopher J D, McNamara, David G, Alsweiler, Jane Marie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2020
Materias:
Paediatrics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7577061/
https://www.ncbi.nlm.nih.gov/pubmed/33082191
http://dx.doi.org/10.1136/bmjopen-2020-038271

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7577061/
https://www.ncbi.nlm.nih.gov/pubmed/33082191
http://dx.doi.org/10.1136/bmjopen-2020-038271

Ejemplares similares